In this GEN and IPM webinar, sponsored by Ultivue, our distinguished presenter, Dr. Keith Wharton, will discuss the utility of advanced multiplexing techniques to provide the much-needed insight affording a comprehensive study of cellular composition, cellular functions, and cell-cell interactions within the tumor microenvironment.
In this GEN webinar, sponsored by Unchained Labs, we’ll examine data generated from Stunner from multiple AAV samples generated from at-scale manufacturing campaigns at Vigene Biosciences (now a Charles River Laboratories company).
In this GEN webinar, sponsored by Akoya, our distinguished presenter, Dr. Karen Willard-Gallo from Institut Jules Bordet, will share her study findings on TLS, T follicular helper cells (Tfh), and B cells in human breast cancer.
In this GEN webinar, sponsored by WuXi, our distinguished presenters, Dr. Heather Malicki and Dr. Andreas Solomos will discuss the regulatory requirements and challenges involved with bringing new AAV-based gene therapies to market.
In TOMORROW's GEN webinar, sponsored by Precision NanoSystems, our distinguished speaker, Dr. Ethan Settembre, will introduce us to the intricacies of saRNA and how it elicits immune responses. Moreover, he will describe the differences between saRNA vs. mRNA, how saRNA can be applied to generate influenza and COVID-19 vaccines, and why it may represent the future of RNA therapeutic development.